A survey of the prevalence of chronic arthritic conditions was carried out on a population of 35 251 patients registered with 29 general practitioners in the highlands of Scotland.
were found in 2*1 per 1000, polymyalgia rheumatica/temporal arteritis in 1-2 per 1000, and gout in 3-4 per 1000. Juvenile chronic arthritis had a prevalence of 0-39 per 1000 (2.0 per 1000 in those aged 15 years and younger) and connective tissue disease 0-45 per 1000.
There was considerable variation in the prevalence of inflammatory arthritis throughout the region. The highest prevalence of rheumatoid arthritis was 14*5 per 1000 women in one east coast area and the lowest 5-2 per 1000 women in the west. The difference did not seem to be due to misclassification.
A consultant's review of a questionnaire sent to all except those with osteoarthritis changed the proportions of patients who could be confirmed to have the respective inflammatory arthritides (rheumatoid arthritis between 3*4 and 5-0 per 1000, seronegative arthritides 2-0 per 1000, juvenile chronic arthritis 0-52 per 1000), and a third of those diagnosed as having rheumatoid arthritis failed to meet hospital oriented diagnostic criteria.
On the other hand, studies of health care provision may more reasonably consider only cases of symptomatic disease.
The Highland Arthritis Prevalence Study (HARPS) was designed to assess the prevalence of chronic rheumatic disease in a large geographical area with a single regional rheumatological service which uniquely encompasses east and west coasts of Great Britain.
Patients and methods
The Highland Health Board provides health care for the Highland region (population 200 800) with additional specialist provision to the Western Isles (population 31 500) and some cross boundary flow from the West Grampian region (population 84 800). The population served is comparable with that of an average United Kingdom health district but is scattered over a vast geographical area (9804 square miles) larger than Wales (fig 1) .
The Highland Health Board has a single consultant with an interest in rheumatology based in Inverness and inpatient facilities for rheumatology are provided by the 15 bedded Nicolson MacKenzie hospital in the spa village of Strathpeffer. Outpatients are seen in Inverness and at peripheral clinics. The region is therefore well defined geographically and served by a single major hospital providing an ideal environment for epidemiological study.
The Highland region is served by 162 general practitioners, including 36 single handed practitioners. Thirty general practitioners from nine general practices initially agreed to take part in the study. They were chosen as representatives of urban and rural practices respectively on the east and west coasts of the area (fig 1) Prevalence of chronic arthritis in the Scottish Highlands (fig 2) . There was a slight female excess but little regional variation. Based on the general practitioner's own diagnosis rheumatoid arthritis was the most prevalent inflammatory arthritis with an overall prevalence of 5 5 per 1000 (6-9 per 1000 for those aged more than 15 years). There was a two to threefold female preponderance (table 4) and the prevalence rose from under 10 per 1000 women at age 40-50 years to a peak of 23 per 1000 women aged 60-70 (fig 3) . There was a threefold difference in prevalence between the Black Isle (9 3 per 1000) and Skye (3 3 per 1000).
Seronegative arthritides, including ankylosing spondylitis, psoriatic arthritis, and Reiter's disease, had an overall prevalence of 2-1 per 1000, less than half that of rheumatoid arthritis. There was a reversal of the female predominance seen in rheumatoid arthritis, and in some areas the male prevalence of seronegative arthritis exceeded that of rheumatoid arthritis. Other inflammatory arthritides were less common. Juvenile chronic arthritis had a prevalence of 0-39 per 1000 (2-0 per 1000 for those aged 15 years and younger) and polymyalgia rheumatica was reported in 1-2 per 1000 population. There were more women than men with both juvenile chronic arthritis (0-6 per 1000 women v 0-2 per 1000 men) and polymyalgia rheumatica/temporal arteritis (table 4). Connective tissue disease was rare (overall prevalence 0 45 per 1000), and the numbers were too small (16) to make any comparisons between areas. Numerically, osteoarthritis of the elderly is the major problem, the prevalence of symptomatic osteoarthritis rising from 10% in those aged 50-60 to nearly 25% of those over 80. The study of the Royal College of General Practitioners found an episode rate of 29-0 per 1000 for osteoarthritis in a large general practice based study but only included those who attended their doctor complaining of their joint symptoms during the study.3
An American study estimated the prevalence of clinical osteoarthritis at 12-1% of the adult population.4 Community based screening programmes in several countries have shown radiological signs of osteoarthritis to be virtually universal in the elderly,4 5 but these figures are of little value in assessing the impact of symptomatic disease on health resources. At present the management of this condition includes drugs, physiotherapy, and orthopaedic surgery, including joint replacement. Demand for surgery is growing steadily, partly because ofits efficacy and partly because ofthe increasing elderly (and hence osteoarthritic) population. Provision of facilities currently follows and hence lags behind demand, which has resulted in long waiting lists for joint replacement surgery. There are no good estimates of the optimal provision of this facility to aid health planners.
Inflammatory arthritis as exemplified by rheumatoid arthritis and seronegative arthritis is much less common than osteoarthritis. Because these two diseases begin in middle life and because they are often chronic they also place large demands on health and other social resources. Our current estimate of the overall prevalence of rheumatoid arthritis in the Highland region lies between 0-34 and 0-55% of the population.
Previous studies in Western societies have shown variable prevalences dependent on the criteria for diagnosis and the population studied.' Strict diagnostic criteria which identify chronic disease produce lower prevalences than widely used criteria which identify many cases of apparently self limiting inflammatory arthritis. A consensus for the prevalence of rheumatoid arthritis in the developed world would be 1% of the adult population.' 2 4 Our current figure is lower than this but cannot be compared directly with most studies owing to differences in the methodology. A more comparable study, such as the morbidity statistics from general practice, recorded an episode rate of 5 9 per 1000 population for rheumatoid arthritis and allied conditions.3 Although comparable with our own figure, this study did not distinguish other inflammatory arthritides and only included patients who attended for a consultation about their arthritis during the study period. The study was carried out in volunteer practices in England and Wales, which might not have been representative. Nevertheless, this study supports our own estimate of rheumatoid arthritis as being considerably less than that previously cited, and it may be that the prevalence of rheumatoid arthritis is actually falling.
We also noticed the commonly found 
